CompoAtlas

Fenugrec

Food supplement declared in France, declaration No 2017-11-494, decision dated 14 November 2017

Fenugrec (Majnature) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Majnature
Food business operator placing the product on the market
Laboratoires IPHYM
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
6 gélules
Directions for use
1 à 2 gélules matin, midi et soir
Not recommended for (according to the manufacturer)
Femmes enceintes

Declaration 152219, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Trigonella foenum-graecum L.GrainePoudre (de plantes séchées ou broyées)1.41 g

Additives

E470b, Hydroxypropyl Méthyl Cellulose

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

l'emploi de ce complément alimentaire est déconseillé chez la femme enceinte sans avis médical.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : Majnature

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line